Natixis Advisors LLC Has $461,000 Stock Position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Natixis Advisors LLC lowered its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 4.4% during the first quarter, Holdings Channel reports. The institutional investor owned 26,398 shares of the real estate investment trust’s stock after selling 1,204 shares during the period. Natixis Advisors LLC’s holdings in Sabra Healthcare REIT were worth $461,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. UMB Bank n.a. grew its stake in Sabra Healthcare REIT by 379.6% during the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust’s stock worth $36,000 after buying an additional 1,621 shares in the last quarter. Assetmark Inc. grew its stake in Sabra Healthcare REIT by 37.8% during the first quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust’s stock worth $63,000 after buying an additional 989 shares in the last quarter. Fifth Third Bancorp grew its stake in Sabra Healthcare REIT by 110.3% during the first quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust’s stock worth $67,000 after buying an additional 2,011 shares in the last quarter. GF Fund Management CO. LTD. acquired a new stake in Sabra Healthcare REIT during the fourth quarter worth about $74,000. Finally, Harbor Capital Advisors Inc. grew its stake in Sabra Healthcare REIT by 17.2% during the first quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust’s stock worth $76,000 after buying an additional 642 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Insider Activity at Sabra Healthcare REIT

In related news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the completion of the sale, the director directly owned 64,725 shares in the company, valued at $1,179,289.50. This represents a 14.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 1.10% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on SBRA. Scotiabank boosted their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a research note on Monday, June 23rd. JMP Securities boosted their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a research note on Wednesday, August 6th. Three research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $20.00.

Sabra Healthcare REIT Stock Down 0.5%

Sabra Healthcare REIT stock opened at $18.64 on Tuesday. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.60 and a fifty-two week high of $20.03. The stock has a market cap of $4.47 billion, a PE ratio of 24.52, a price-to-earnings-growth ratio of 1.55 and a beta of 0.86. The firm’s 50-day simple moving average is $18.27 and its 200 day simple moving average is $17.57. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.02. The business had revenue of $189.15 million during the quarter, compared to analyst estimates of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.36 EPS. Research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Friday, August 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.4%. Sabra Healthcare REIT’s dividend payout ratio is 157.89%.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.